|
General Information
|
|
|
Product
|
IL17A Peptide
|
|
Description
|
Antigenic Blocking Peptide Interleukin-17A
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 110-150 on human Interleukin-17A precursor protein.
|
|
Accession #
|
NCBI: NP_002181
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q96F46
|
|
Overview
|
Receptor for IL17A, IL17F and, in dimer with IL17RE, for IL17C. Binds its IL17A ligand with low affinity, suggesting that additional components are involved in IL17A-induced signaling.
|
|
Molecular Function
|
interleukin-17 receptor activity
|
|
Subcellular Location
|
Isoform 1: membrane, single-pass type I membrane protein; Isoform 2: secreted
|
|
Expression
|
Widely expressed.
|
|
Alternative Nomenclature
|
CTLA 8 antibody
Cytotoxic T lymphocyte associated serine esterase 8 antibody
IL-17A antibody
IL17 antibody
Interleukin 17 (cytotoxic T lymphocyte associated serine esterase 8) antibody
Interleukin 17A antibody
OTTHUMP00000016597 antibody
OTTMUSP00000046003 antibody
|
| |
|
IL17A Antibody
IL17A Antibody FITC
IL17A Antibody BIOTIN
IL17A Positive Control
